STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] AMPHENOL CORP /DE/ SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Amphenol (APH) received a Rule 144 notice for a proposed sale of 120,000 shares of Common Stock through Morgan Stanley Smith Barney LLC on 10/31/2025 on the NYSE. The filing lists an aggregate market value of $16,956,384 for the shares to be sold.

The shares were acquired on 10/31/2025 via exercise of options under a registered plan, paid in cash. The notice also reports a sale during the past three months by Michael Ivas of 50,000 shares on 08/08/2025 for $5,500,820. Shares outstanding were 1,224,055,508.

Positive
  • None.
Negative
  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Amphenol Corp

NYSE:APH

APH Rankings

APH Latest News

APH Latest SEC Filings

APH Stock Data

170.28B
1.22B
0.56%
96.96%
1.45%
Electronic Components
Electronic Connectors
Link
United States
WALLINGFORD